Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in REPL — Replimune Group, Inc.

CIK 1692234 Seattle, WA
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$660,203
+$419,292 QoQ
Shares Held
59,639
+89.4% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 199 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. REPL ranks #138 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in REPL

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $660,203 59,639
2026-03-31 $240,911 31,492
2025-12-31 $78,935 8,121
2025-09-30 $32,584 7,777
2025-06-30 $1,932 208
2025-03-31 $2,349 241
2024-12-31 $2,918 241
2024-09-30 $323,548 29,521
2024-06-30 $133,488 14,832
2024-03-31 $139,796 17,111
2023-09-30 $21,028 1,229
2023-06-30 $141,572 6,097
2023-03-31 $105,977 6,001